BIOMEDICAL INVESTMENTS

Biomedical Investments (BMI) is an Israeli-based private investment firm, which specializes in the healthcare field (medical devices and biotechnology). The company focuses its investments on start-ups with breakthrough technologies, applicable in emerging therapeutic segments. Among the company's investors are: Mr. Leonard Abramson, who is a shareholder and member of the board, Teva Pharmaceuticals, which develops, manufactures and markets generic and branded human pharmaceuticals, Arison Investments, which is an Israeli investment group and Professor Benad Goldwasser, who is shareholder and Managing director of the company.

#Financial #More

BIOMEDICAL INVESTMENTS

Founded:
1997-01-01

Status:
Closed

Technology used in webpage:
012 Smile


Investments List

Date Company Article Money raised
2006-09-27 Gamida Cell Biomedical Investments investment in Series D - Gamida Cell 16 M USD
2006-07-24 TransPharma Medical Biomedical Investments investment in Series C - TransPharma Medical 18 M USD
2004-08-09 ColBar LifeScience Ltd. Biomedical Investments investment in Series D - ColBar LifeScience Ltd. 7.25 M USD
2003-01-18 TransPharma Medical Biomedical Investments investment in Series B - TransPharma Medical 8.9 M USD
2001-05-15 Remon Medical Technologies Biomedical Investments investment in Series A - Remon Medical Technologies 10 M USD
2001-01-01 TransPharma Medical Biomedical Investments investment in Series A - TransPharma Medical 6.5 M USD

More informations about "Biomedical Investments"

Biomedical Investments - Investments, Portfolio & Company Exits

Biomedical Investments 's most notable exits include Gamida Cell, ... Which industries has this organization had the most exits in? Show . Gamida Cell Gamida Cell is a biopharmaceutical โ€ฆSee details»

Biomedical Investments - Crunchbase Investor Profile & Investments

Biomedical Investments provides its investments to early-stage digital health startup companies. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... 9,014 โ€ฆSee details»

Biomedical Investments โ€” 5 Portfolio companies, 7 Investments, โ€ฆ

This Biomedical Investments works on 38 percentage points more the average amount of lead investments comparing to the other organizations. The typical case for the fund is to invest in โ€ฆSee details»

OBIO®

OBIO® supports early-stage and venture-backed life sciences and health tech companies enabling them to raise capital, hire and train industry-ready talent, facilitate the โ€ฆSee details»

Industry Analysis Reports - BIO

The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... This report investigates recent investment into antibacterial innovation and the โ€ฆSee details»

Home | Global Health Investment Corporation (GHIC)

Global Health Security Portfolio In partnership with the Biomedical Advanced Research and Development Authority (BARDA), within the Administration for Strategic Preparedness and Response, at the U.S. Department of Health and โ€ฆSee details»

World Report: an interactive mapping database of โ€ฆ

Apr 25, 2023 World Report is an interactive, open-access online database and mapping tool of global research investments. The site depicts direct and indirect awards supported by some of the worldโ€™s largest biomedical research funders โ€ฆSee details»

2024 Biomedical Pitch Competition Invitation(็”Ÿ็‰ฉๅŒป็–— โ€ฆ

2024 Biomedical Pitch Competition. ... Boston Chinese Investment Club is a non-profit organization founded in 2010 with nearly 10,000 members in Finance, Venture Capital, and various technology industries. It serves as Boston โ€ฆSee details»

Investments on grants for biomedical research by funder, type of โ€ฆ

Presented here is information on investments on biomedical grants for 2022 by 10 funders that reported these data to World RePORT. See more about the scope and limitations of World โ€ฆSee details»

Biomedical Investments - Investments, Portfolio & Company Exits

Sep 20, 2022 Biomedical Investments has invested in BioAI Health on Sep 20, 2022. This investment - Seed Round - BioAI Health - was valued at . obfuscated. obfuscated. How many โ€ฆSee details»

Meet the 5 most active PE investors in life sciences

Dec 4, 2023 PE investments in life sciences peaked in 2021, when investors closed 695 PE transactions totaling $127.5 billion, according to PitchBook data. ... including a more than $7 โ€ฆSee details»

Biomedical innovation | Deloitte Insights

May 23, 2023 Contrary to popular belief, government and nongovernmental institutional investment in biomedical areas do not reduce private spending on R&D. 65 In fact, private โ€ฆSee details»

Major investments in domestic firms to rebuild Canadaโ€™s ...

Mar 16, 2021 Canadians have demonstrated a remarkable ability to mobilize in response to the COVID 19 pandemic. Companies in the biomanufacturing space from coast to coast to coast โ€ฆSee details»

Just how good an investment is the biopharmaceutical sector?

Uncertainty surrounding the risk and reward of investments in biopharmaceutical companies poses a challenge to those interested in funding such enterprises. Using data on publicly โ€ฆSee details»

Federal Budget Recognizes Strategic Importance of Canadaโ€™s โ€ฆ

Apr 19, 2021 $250 million over four years, starting in 2021-22, for the federal research granting councils to create a new tri-council biomedical research fund. $92 million over four years, โ€ฆSee details»

Canadaโ€™s new biomanufacturing and life sciences investment

Around the world, the COVID-19 pandemic has highlighted each countryโ€™s need for strong and dependable biomanufacturing infrastructure. The Canadian government, along with various โ€ฆSee details»

Adamant Biomedical Investments AG - Crunchbase

Adamant Biomedical Investments is a Swiss asset manager with exclusive focus on healthcare. Their core competence is research. Their services include advisory and portfolio management โ€ฆSee details»

40 Non-profit Companies Worldwide - Biotech Careers

The Applied Biomedical Science Institute (ABS Institute) is a 501(c)(3) ... Bay Area Bioscience Education Community (BABEC) Business Area(s): Education; Non-profit; ... Geneva is a โ€ฆSee details»

Shanghai Biomedical Industrial Equity Investment Fund

Shanghai Biomedical Industrial Equity focuses on areas that are in line with the development strategy of the biomedical industry. ... Shanghai Biomedical Industrial Equity Investment Fund โ€ฆSee details»

Banu Onaral, Pioneer of Biomedical Engineering | Drexel BME

Dec 17, 2024 Prof. Dr. Banu Onaral, a pioneering biomedical engineer, visionary academic leader, and global innovator, passed away peacefully on December 17, 2024, at the age of 75. โ€ฆSee details»